Taken together, JAK/STAT-associated signaling pathways play a multifaceted role in GC carcinogenesis and are ideal for the combinatorial targeted therapies which could be explored as a potential for the identification of novel biomarkers for GC treatment. Here, SOAT1 is linked to gastric cancer.